FDA panel unanimously backs Regeneron eye drug

Friday, June 17, 2011 - 12:31 in Health & Medicine

WASHINGTON (AP) -- A panel of federal health experts has unanimously voted in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net